RESUMEN
Acute respiratory infection (ARI) is the most common infection in children under 5â¯years of age and it is frequently caused by two pneumoviruses, human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV). Epidemic seasons of these viruses overlap and disease manifestations are highly similar, including severe lower ARI such as bronchiolitis or pneumonia. Reinfections with pneumoviruses are frequent and limited prevention treatment is available. Genetic diversity of HRSV and HMPV strains circulating in Croatia was monitored during four consecutive years (2014-2017). Co-circulation of multiple lineages was observed for both viruses. Within HRSV group A, ON1 strains gained strong predominance during the 4-year period, while previously dominant genotype NA1 was detected only sporadically. Similarly, newly occurring HMPV genotype A2c gained predominance over genotype A2b during this period, resulting in all infection in 2017 being caused by A2c. Along with phylogenetic analysis based on the commonly used fragments for detection and genotyping of these viruses, full length G and SH genes were also analysed. Evolutionary dynamics showed that inferred substitution rates of HRSV and HMPV are between 2.51â¯×â¯10-3 and 3.61â¯×â¯10-3 substitutions/site/year. This study established presence of recently described HMPV strains containing large duplications in the G gene in Croatia. Viruses with either of the two duplications belong to a subcluster A2c, which has completely replaced all other group A subclusters in 2017.
Asunto(s)
Metapneumovirus/clasificación , Infecciones por Paramyxoviridae/epidemiología , Infecciones por Virus Sincitial Respiratorio/epidemiología , Virus Sincitial Respiratorio Humano/clasificación , Infecciones del Sistema Respiratorio/virología , Niño , Preescolar , Croacia/epidemiología , Sustitución de Medicamentos , Evolución Molecular , Femenino , Humanos , Lactante , Masculino , Metapneumovirus/genética , Metapneumovirus/aislamiento & purificación , Epidemiología Molecular , Filogenia , Virus Sincitial Respiratorio Humano/genética , Virus Sincitial Respiratorio Humano/aislamiento & purificaciónRESUMEN
Aedes (Hulecoeteomyia) japonicus japonicus (Theobald, 1901) has recently established across North America and Central Europe. A 3-year survey was conducted in northwestern Croatian regions from 2013 to 2015 using mosquito ovitraps at possible points of entry and house yards, occasionally complemented by larval collections from cemetery vases. In the first year, the survey investigated the county bordering Slovenia, where the first detection of Ae. j. japonicus had taken place on 28 August 2013. During the next 2 years, Ae. j. japonicus was detected in this area from early May until late October. In 2015, several counties further to the east were included in the survey, leading to the detection of Ae. j. japonicus approximately 100 km eastward from the initially surveyed region. Given a moderate continental climate and homogeneous climatic conditions in this part of Europe, the eastward spread of Ae. j. japonicus can be expected to continue.
Asunto(s)
Aedes/fisiología , Distribución Animal , Aedes/crecimiento & desarrollo , Animales , Croacia , Especies Introducidas , Larva/crecimiento & desarrollo , Larva/fisiologíaRESUMEN
Previously we reported on the HPIV2 genotype distribution in Croatia 2011-2014. Here we expand this period up to 2017 and confirm that G1a genotype has replaced G3 genotype from the period 2011-2014. Our hypothesis was that the G1a-to-G3 genotype replacement is an antibody-driven event. A cross-neutralisation with anti-HPIV2 sera specific for either G1a or G3 genotype revealed the presence of genotype-specific antigenic determinants. By the profound, in silico analyses three potential B cell epitopic regions were identified in the hemagglutinin neuraminidase (regions 314-361 and 474-490) and fusion protein (region 440-484). The region identified in the fusion protein does not show any unique site between the G1a and G3 isolates, five differentially glycosylated sites in the G1a and G3 genotype isolates were identified in epitopic regions of hemagglutinin neuraminidase. All positively selected codons were found to be located either in the region 314-316 or in the region 474-490 what indicates a strong positive selection in this region and reveals that these regions are susceptible to evolutionary pressure possibly caused by antibodies what gives a strong verification to our hypothesis that neutralising antibodies are a key determinant in the inherently complex adaptive evolution of HPIV2 in the region.
Asunto(s)
Anticuerpos Neutralizantes/fisiología , Virus de la Parainfluenza 2 Humana/genética , Infecciones por Rubulavirus/virología , Adolescente , Distribución por Edad , Animales , Anticuerpos Antivirales/fisiología , Niño , Preescolar , Chlorocebus aethiops , Croacia/epidemiología , Epítopos de Linfocito B/química , Epítopos de Linfocito B/inmunología , Femenino , Genotipo , Cobayas , Proteína HN/inmunología , Humanos , Lactante , Funciones de Verosimilitud , Persona de Mediana Edad , Virus de la Parainfluenza 2 Humana/clasificación , Virus de la Parainfluenza 2 Humana/inmunología , Filogenia , ARN Viral/química , ARN Viral/genética , Recurrencia , Infecciones por Rubulavirus/epidemiología , Infecciones por Rubulavirus/inmunología , Estaciones del Año , Alineación de Secuencia , Células VeroRESUMEN
Hepatitis E has become an emerging infection in many European countries. We analysed the prevalence of hepatitis E virus (HEV) infection in selected population groups in Croatia. Overall HEV IgG seropositivity was 5.6%, while 1.9% participants showed IgM antibodies suggestive of recent infection. No IgM-positive sample was positive for HEV RNA. HEV IgG antibodies were most prevalent in alcohol abusers (8.9%) and war veterans (8.6%), compared with 6.1% among injecting drug users and 2.7% in healthcare professionals. No individual with high-risk sexual behaviour tested HEV seropositive. HEV IgG positivity increased significantly with age from 1.8% to 2.3% in individuals younger than 40 years to 11.3% in individuals older than 50 years (P = 0.023). The mean age of HEV-positive participants was significantly higher than that of HEV-negative participants (50.9 ± 11.8 years versus 41.2 ± 11.8 years, P = 0.008). Seroprevalence rates were significantly higher in residents of suburban and rural areas compared with residents of urban areas (14.5% versus 2.5%, P = 0.003). Additionally, an increasing prevalence of HEV IgG antibodies was observed from 1.8% in participants living in families with two household members to 12.1% in those living with more than four members (P = 0.046). Gender, marital status, educational level, sexual orientation, source of drinking water, history of blood transfusions, surgical procedures, tattooing and travelling were not associated with HEV seroprevalence. Logistic regression showed that living in suburban/rural areas was the main risk factor for HEV seropositivity (OR = 6.67; 95%CI = 1.89-25.0; AOR = 7.14, 95%CI = 1.89-25.0).
Asunto(s)
Hepatitis E/epidemiología , Estudios Seroepidemiológicos , Adolescente , Adulto , Anciano , Anticuerpos Antivirales , Croacia/epidemiología , Femenino , Hepatitis E/sangre , Virus de la Hepatitis E/inmunología , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Proyectos Piloto , Adulto JovenRESUMEN
Cytomegalovirus (CMV) is an important pathogen in immunocompromised individuals. The aim of this study was to analyze prevalence and dynamics of CMV infection among patients undergoing chronic hemodialysis. From 2010 to 2012, a total of 162 patients and 160 control subjects were tested for the presence of CMV IgM and IgG antibodies using enzyme-linked immunosorbent assay. IgM/IgG reactive samples were further evaluated for IgG avidity to confirm or rule out recent primary CMV infection. The overall IgG seropositivity was higher in hemodialysis patients compared to controls (90.7% vs. 81.9%; crude odds ratio [OR] =2.02, 95% confidence interval [CI] =1.05-3.89; OR adjusted for age and gender = 2.18, 95% CI = 1.05-4.55). CMV IgG antibody titers were similar in both groups. There was no difference in CMV prevalence between males (87.9%) and females (96.3%). According to age, a progressive increase in seropositivity was observed in both hemodialysis patients and the control group. Three hemodialysis patients (1.9%) developed recurrent CMV infection (positive IgM with high avidity IgG antibodies). In one patient (2.9%), seroconversion was documented during the second year of the follow-up period indicating primary infection. In contrast, in the control group, recent primary CMV infection (positive IgM with low/borderline IgG avidity) was demonstrated in three subjects (1.9%), whereas one (0.6%) developed recurrent infection. On multivariate logistic regression, hemodialysis and older age were significant predictors for CMV seropositivity.
RESUMEN
PURPOSE: We report on first evidence of simultaneous occurrence of West Nile virus (WNV) and Usutu virus (USUV) neuroinvasive infection in humans in Croatia during the transmission season 2013. METHODS: From June to December 2013, a total of 95 patients with clinically suspected WNV infection (WNV fever and neuroinvasive disease) were tested for WNV IgM/IgG antibodies using enzyme-linked immunosorbent assay. Twenty-six reactive samples were further tested by virus neutralization test for confirmation. RESULTS: WNV neuroinvasive infection was confirmed in 20 patients, while in three patients USUV neutralizing antibodies were detected. Cases occurred during the 11-week interval (from 24 July to 07 October 2013). Both WNV and USUV cases were distributed in three north-western Croatian counties. In addition to human cases, recent asymptomatic WNV infection (detection of IgM antibodies) was recorded in 9/3,460 (0.3 %) tested sentinel horses. Infected animals were recorded in two eastern and one north-western county. CONCLUSIONS: Our results indicate co-circulation of WNV and USUV in Croatia. WNV infection could be misdiagnosed with other emerging infectious diseases presenting with neurological symptoms such as USUV infection.
Asunto(s)
Brotes de Enfermedades , Encefalitis por Arbovirus/epidemiología , Fiebre del Nilo Occidental/epidemiología , Adulto , Anciano , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Croacia/epidemiología , Virus de la Encefalitis Japonesa (Subgrupo)/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Persona de Mediana Edad , Pruebas de Neutralización , Virus del Nilo Occidental/aislamiento & purificaciónRESUMEN
Epilepsy is one of the most common neurological disorders, while neurocysticercosis caused by Taenia solium infection of the central nervous system currently represents the leading cause of secondary epilepsy in Central and South America, East and South Asia, and sub-Saharan Africa. As a result of increased migration from these endemic regions, neurocysticercosis and subsequent epilepsy are becoming a growing public health problem in developed countries as well. In order to determine the prevalence of T. solium infection in patients with epilepsy in Croatia, a retrospective serological study was conducted. A total of 770 serum samples were tested for the presence of T. solium IgG antibodies using a commercial qualitative enzyme immunoassay. The Western blot technique was used as a confirmatory test for the diagnosis. The overall seroprevalence rate of T. solium infection in patients with clinically proven epilepsy was 1.5%. Although the results have shown that infection with this tapeworm is rare in Croatia, this study hopes to increase awareness about the importance of preventive measures and benefits of accurate and timely diagnosis. Intervention measures for infection control are crucial, namely sanitation improvement, control of domestic pig-breeding, detailed meat inspection, detection and treatment of tapeworm carriers, hand washing and health education.
Asunto(s)
Cisticercosis/epidemiología , Epilepsia/parasitología , Taenia solium/aislamiento & purificación , Adolescente , Adulto , Anciano , Animales , Anticuerpos Antihelmínticos/sangre , Western Blotting , Distribución de Chi-Cuadrado , Niño , Preescolar , Croacia/epidemiología , Cisticercosis/complicaciones , Cisticercosis/inmunología , Epilepsia/epidemiología , Humanos , Técnicas para Inmunoenzimas , Persona de Mediana Edad , Estudios Retrospectivos , Estudios Seroepidemiológicos , Adulto JovenRESUMEN
We describe an outbreak of hand, foot and mouth disease (HFMD) in a childcare centre in a district of Zagreb county, north-west Croatia. A total of eleven cases of HFMD occurred in the childcare centre and another nine were reported from nearby areas in the district. Coxsackie A16 virus was diagnosed in 13 clinical specimens obtained from 11 symptomatic and asymptomatic children. All cases resolved without complications.
Asunto(s)
Cuidado del Niño/estadística & datos numéricos , Brotes de Enfermedades/estadística & datos numéricos , Virus de la Fiebre Aftosa , Fiebre Aftosa/epidemiología , Fiebre Aftosa/virología , Vigilancia de la Población , Animales , Niño , Croacia/epidemiología , Femenino , Humanos , Incidencia , Masculino , Medición de Riesgo/métodos , Factores de RiesgoRESUMEN
After information about a dengue case in Germany acquired in Croatia, health professionals and the public in Croatia were alerted to assess the situation and to enhance mosquito control, resulting in the diagnosis of a second case of autochthonous dengue fever in the same area and the detection of 15 persons with evidence of recent dengue infection. Mosquito control measures were introduced. The circumstances of dengue virus introduction to Croatia remain unresolved.
Asunto(s)
Antígenos Virales/sangre , Virus del Dengue/aislamiento & purificación , Dengue/diagnóstico , Control de Mosquitos , Estudios de Casos y Controles , Croacia , Dengue/transmisión , Dengue/virología , Virus del Dengue/genética , Virus del Dengue/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Alemania , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , ViajeRESUMEN
Cystic liver disease (CLD), presenting with solitary or multiple cysts in the liver, is a common diagnosis today, primarily due to the frequent application of modern radiological methods. There is a wide range of possible causes. CLD of infective origin is usually caused by an echinococcal species. During the past three decades a number of cystic echinococcosis (CE) control programmes have led to a significant decrease in the incidence of human hydatidosis in some endemic areas. The aim of this study was to determine the seroprevalence of E. granulosus infection in Croatian patients with CLD. A total of 540 serum samples from patients with hepatic cysts detected by imaging methods were screened for the presence of E. granulosus IgG antibodies using semiquantitative enzyme-linked immunosorbent assay. The Western blot technique was used as a confirmatory test for the CE diagnosis. The overall E. granulosus seroprevalence rate in patients with CLD was 3.9%. There was no significant difference in seroprevalence rate between male and female patients (P = 0.541). According to age groups, there was a significant difference in seropositivity among age groups (P = 0.002). The highest seroprevalence rate was detected in the youngest age group (up to 18 years), both in males and females (20% and 13%, respectively). This study indicates that CE still represents a public health problem in Croatia. Preventive measures should be used to control Echinococcus infections, including avoidance of contact with infected dogs, egg-contaminated soil or plants; control and treatment of dogs with antihelmintics; hand washing, improved sanitation and health education.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Equinococosis Hepática/epidemiología , Echinococcus granulosus/inmunología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Animales , Western Blotting , Niño , Preescolar , Croacia/epidemiología , Equinococosis Hepática/diagnóstico por imagen , Equinococosis Hepática/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunoglobulina G/sangre , Lactante , Recién Nacido , Hígado/diagnóstico por imagen , Hígado/patología , Masculino , Persona de Mediana Edad , Radiografía , Estudios Seroepidemiológicos , Factores Sexuales , Adulto JovenRESUMEN
We describe excretion of measles vaccine strain Schwarz in a child who developed a febrile rash illness eight days after primary immunisation against measles, mumps and rubella. Throat swabs and urine specimens were collected on the fifth and sixth day of illness, respectively. Genotyping demonstrated measles vaccine strain Schwarz (genotype A). If measles and rubella were not under enhanced surveillance in Croatia, the case would have been either misreported as rubella or not recognised at all.
Asunto(s)
Exantema/etiología , Virus del Sarampión/aislamiento & purificación , Vacuna contra el Sarampión-Parotiditis-Rubéola/efectos adversos , Sarampión/prevención & control , Faringe/virología , Croacia , Exantema/virología , Fiebre/etiología , Genotipo , Humanos , Lactante , Inyecciones Subcutáneas , Sarampión/inmunología , Sarampión/orina , Virus del Sarampión/genética , Virus del Sarampión/fisiología , Vacuna contra el Sarampión-Parotiditis-Rubéola/inmunología , Paperas/inmunología , Paperas/prevención & control , Reacción en Cadena de la Polimerasa , Rubéola (Sarampión Alemán)/inmunología , Rubéola (Sarampión Alemán)/prevención & control , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/efectos adversos , Vacunas Atenuadas/genética , Vacunas Atenuadas/aislamiento & purificaciónRESUMEN
We report on three cases of symptomatic transmission of the L-Zagreb mumps vaccine virus from three vaccinated children to five adult contacts. The five contact cases were parents of the vaccinated children and presented with parotitis and in one case also with aseptic meningitis. The etiology of the contacts' illness was determined by viral culture, genomic sequencing, serology and epidemiological linking. Two of the vaccinated children developed vaccine associated parotitis as an adverse event three weeks following immunization. Symptoms in contact cases developed five to seven weeks after the vaccination of the children. The five contact cases, as well as the three children with adverse events recovered completely. The children had been vaccinated with MMR vaccine produced by the Institute of Immunology Zagreb, each of them with a different lot. One of the possible explanations for these adverse events is that the very low levels of wild mumps virus circulation in the last decade, combined with waning immunity in those who received one dose of vaccine or suffered from mumps in childhood, resulted in susceptible young adults and that this unique epidemiological situation allows us to detect horizontal transmission of mumps vaccine virus.